Aripiprazole for pregnant women: safety
Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000826
English
Authors' recommendations:
One non-randomized study was identified regarding the safety and harms of aripiprazole in pregnant women.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/nov-2014/RB0747%20Safety%20of%20Abilify%20and%20Prozac%20in%20Pregnancy%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Pregnancy
- Antipsychotic Agents
- Fetus
- Maternal Exposure
- Pregnant Women
- Prenatal Exposure Delayed Effects
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.